FT-1518
FT-1518 is a new generation selective, potent and oral bioavailable mTORC1 and mTORC2 inhibitor, and exhibits antitumor activity.
Product Specifications
CAS Number
[1313026-58-2]
UNSPSC
12352005
Target
MTOR
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/FT-1518.html
Purity
98.62
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCC(N1C2=NC(N3CC4OC(CC4)C3)=NC(C5=NC=C(N)N=C5)=C2N=C1)CC
Molecular Formula
C20H26N8O
Molecular Weight
394.47
References & Citations
[1]Alain C. Mita, et al. Abstract 137: FT-1518, a new generation selective and potent mTORC1 and mTORC2 inhibitor: an in vitro and in vivo profile. Cancer Res 2017;77 (13 Suppl) .
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MTORC1; mTORC2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1129532-01 0.02 mg (E-Coli)
Recombinant Phelline comosa Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details 
MBS1129532-02 0.02 mg (Yeast)
Recombinant Phelline comosa Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details MBS1129532-03 0.1 mg (E-Coli)
Recombinant Phelline comosa Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details